Company Filing History:
1 out of 4,874 
1 out of 42 Years Active: 2016
Title: Albane Gaubert: Innovator in Cancer Treatment
Introduction
Albane Gaubert is a notable inventor based in Saint Cloud, France. She has made significant contributions to the field of cancer research through her innovative work on peptides. Her research focuses on the interaction between histones and the Asf1 histone chaperone, which plays a crucial role in cancer treatment.
Latest Patents
Albane Gaubert holds a patent titled "Peptides that inhibit the interaction between ASF1 and histones, and use thereof." This invention relates to peptides capable of inhibiting the formation of the complex between the Asf1 histone chaperone and histones H3-H4. The use of these peptides as a drug, particularly for treating cancer, highlights the potential impact of her work in medical science. She has 1 patent to her name.
Career Highlights
Throughout her career, Albane has worked with prestigious organizations such as the Commissariat à l'Énergie Atomique et aux Énergies Alternatives and Université Pierre et Marie Curie (Paris VI). Her experience in these institutions has allowed her to advance her research and contribute to significant scientific advancements.
Collaborations
Albane has collaborated with esteemed colleagues, including Francoise Ochsenbein and Raphael Guerois. These partnerships have enriched her research and fostered a collaborative environment for innovation.
Conclusion
Albane Gaubert's work in developing peptides for cancer treatment exemplifies her dedication to advancing medical science. Her innovative approach and collaborations with leading institutions and researchers underscore her impact in the field.